Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
03/2012
03/22/2012US20120071505 Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress
03/22/2012US20120071504 Modulators of cystic fibrosis transmembrane conductance regulator
03/22/2012US20120071485 Therapeutic Compositions And Methods
03/22/2012US20120071470 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
03/22/2012US20120071466 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
03/22/2012US20120071450 Organic compounds
03/22/2012US20120071448 S1P3 Receptor Inhibitors for Treating Conditions of the Eye
03/22/2012US20120071431 Platycodin Radix Extracts, and Their Use in Treating Disease Conditions Associated with Angiogenesis
03/22/2012US20120071423 Heterotricyclic AMPA Receptor Antagonists for Treatment of Epilepsy, Pain, and Other Neurological Disorders and Diseases
03/22/2012US20120071411 Lkktet and/or lkktnt peptide compositions which are lyophilized or in a form capable of being lyophilized
03/22/2012US20120070467 Ophthalmic Drug Delivery
03/22/2012US20120070428 Treatment of vascularized pigment epithelial detachment with anti-vegf therapy
03/22/2012US20120070422 Method of Treating Ocular Disorders
03/22/2012US20120070402 Polymeric artificial tear system
03/22/2012US20120070401 Composition and Method for Promoting Wound Healing
03/22/2012US20120070377 Compounds and biological materials and uses thereof
03/22/2012US20120070372 Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
03/22/2012US20120070369 Hif inhibitors and use thereof
03/22/2012CA2812197A1 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for lowering intraocular pressure
03/22/2012CA2812191A1 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating retinal diseases
03/22/2012CA2811559A1 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol
03/21/2012EP2429569A2 Treatment of eye diseases using encapsulated cells encoding and secreting a neuroprotective factor and/or an anti-angiogenic factor
03/21/2012EP2429507A2 Phosphate-free pharmaceutical composition for the treatment of glaucoma
03/21/2012EP2288598B1 Thiophene derivatives useful as ocular hypotensive agents
03/21/2012EP1439174B1 4-IMIDAZOLIN-2-ONE COMPOUNDS AS p38 MAP KINASE INHIBITORS
03/21/2012EP1436624B1 A method of diagnosis and treatment and agents useful for same
03/21/2012CN1441770B Modified forms of pharmacologically active agents and uses therefor
03/21/2012CN102380098A Combination therapy for the treatment of ocular neovascular disorders
03/21/2012CN102380096A Medicine combination containing fusion protein for suppressing angiogenesis and application
03/21/2012CN102379977A Chinese wolfberry nutrition eye mask
03/21/2012CN102379874A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
03/21/2012CN102379867A Use of chicoric acid in treatment of fundus lesion
03/21/2012CN102178815B Traditional Chinese medicine for treating ischemic optic neuropathy
03/21/2012CN101757074B Chewable tablet prepared from berberis
03/21/2012CN101628905B C-aryl glucoside sglt2 inhibitors and method
03/21/2012CN101606989B Novel preparation method of trollius chinensis granular preparation
03/21/2012CN101432009B Preventative treatment and remission of allergic diseases
03/21/2012CN101370505B Treatment of ocular neovascular disorders such as macular degeneration, angiod streaks, uveitis and macular edema
03/21/2012CN101130071B Vaccine
03/21/2012CN101007803B Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
03/20/2012US8138353 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
03/20/2012US8138311 Modified proteins, designer toxins, and methods of making thereof
03/20/2012US8138195 Inhibitors of human phosphatidylinositol 3-kinase delta
03/20/2012US8137934 Regeneration and neogenesis of retinal photoreceptor cell using Otx2 gene
03/20/2012US8137662 Proliferated cell lines and uses thereof
03/20/2012CA2563659C Method of treating dry eye disorders and uveitis
03/20/2012CA2553423C Heterocyclic compounds for use in the treatment of cancer and the inhibition of angiogenesis
03/15/2012WO2012034079A2 Macrolide dosage forms
03/15/2012WO2012033789A2 Treatment of diseases
03/15/2012WO2012033348A2 Composition for the prevention or treatment of allergic diseases comprising 2-linoleoyl glycerol
03/15/2012WO2012033189A1 Agent for treatment of dry eye characterized by combining p2y2 receptor agonist with hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof
03/15/2012US20120065380 Dual targeting antibody of novel form, and use thereof
03/15/2012US20120065270 Potassium ion channel modulators and uses thereof
03/15/2012US20120065258 Stable prostaglandin-containing compositions
03/15/2012US20120065228 Compositions and methods for treating, controlling, reducing, or ameliorating ocular inflammatory with lower risk of increased intraocular pressure
03/15/2012US20120065227 TRIAZOLOPYRIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
03/15/2012US20120065199 Substituted quinolines for use as vegf inhibitors
03/15/2012US20120065191 Pharmaceutical compounds
03/15/2012US20120065189 Heterocyclic compounds for the treatment of stress-related conditions
03/15/2012US20120065187 Heterocyclic inhibitors of histamine receptors for the treatment of disease
03/15/2012US20120065185 Substituted alkylamine derivatives and methods of use
03/15/2012US20120065180 Androgen pharmaceutical composition and method for treating depression
03/15/2012US20120065178 Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues
03/15/2012US20120065173 Chemical compounds
03/15/2012US20120065155 A3 adenoside receptor agonists for the reduction of intraocular pressure
03/15/2012US20120065153 Azasugar derivatives, heparanase inhibitors, method for preparing same, compositions containing same, use thereof
03/15/2012US20120065131 Compositions and methods for topical application and transdermal delivery of an oligopeptide
03/15/2012US20120064625 Nucleic Acids, Polypeptides, Compositions, and Methods for Modulating Apoptosis
03/15/2012US20120064157 Pharmaceutical composition and administrations thereof
03/15/2012US20120064155 Oral pharmaceutical composition for use in respiratory diseases
03/15/2012US20120064124 Macrolide dosage forms
03/15/2012US20120064123 Composition for a topical ophthalmic clear colloidal liquid which undergoes a liquid-gel phase transition in the eye
03/15/2012US20120064094 Serotonin 5-HT3 Receptor Antagonists for Use in the Treatment of Lesional Vestibular Disorders
03/15/2012US20120064077 Stable and soluble antibodies inhibiting tnf alpha
03/15/2012US20120064048 Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
03/15/2012US20120064010 CCR3 and its Ligands Are Therapeutic and Diagnostic Targets for Neovascular Age-Related Macular Degeneration
03/15/2012US20120064004 Isotopologues of thalidomide
03/15/2012US20120064001 Anti-VEGF Antibody Compositions and Methods
03/15/2012US20120063997 Delivery system with scaffolds
03/15/2012US20120063996 Novel nimesulide compositions
03/15/2012CA2810537A1 Compositions for a topical ophthalmic clear colloidal liquid which undergoes a liquid-gel phase transition in the eye
03/15/2012CA2810481A1 Agent for treatment of dry eye characterized by combining p2y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof
03/14/2012EP2428234A1 Composition for use in treating retinal cell death and in reducing intraocular pressure
03/14/2012EP2428210A1 Use of serum amyloid A gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
03/14/2012EP2427491A2 Compositions and methods for antibodies targeting complement protein c3b
03/14/2012EP2427189A1 S1p3 receptor inhibitors for treating conditions of the eye
03/14/2012EP2427052A1 Methods and compositions for treating ophthalmic conditions
03/14/2012EP2049112B1 Treating infections and sequelae thereof with combined dissociated glucocorticoid receptor agonists and anti-infective agents
03/14/2012CN1558774B Angiotensin peptide-carrier conjugates and uses thereof
03/14/2012CN102378814A Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
03/14/2012CN102378753A Plasminogen activator inhibitor-1 inhibitor
03/14/2012CN102373140A Red wine and its preparation method
03/14/2012CN102372794A Method for preparing chondroitin sulfate
03/14/2012CN102372653A Diphenyl methanol derivative, preparation method thereof and application of diphenyl methanol derivative in medicine
03/14/2012CN102370906A Traditional Chinese medicinal combination with function of relieving asthenopia and preparation method thereof
03/14/2012CN102370891A Method for authenticating dendrobium officinale by using HPLC fingerprint
03/14/2012CN102370865A Medicine used for treating suppurative otitis media
03/14/2012CN102370830A Eyesight-improving massage Chinese medicinal preparation and preparation method thereof
03/14/2012CN102370826A Traditional Chinese medicine powder for treating deafness
03/14/2012CN102370820A Medicine for treating trachoma
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 531